| Literature DB >> 11854322 |
Peipei Ping1, Changxu Song, Jun Zhang, Yiru Guo, Xinan Cao, Richard C X Li, Wenjian Wu, Thomas M Vondriska, Jason M Pass, Xian-Liang Tang, William M Pierce, Roberto Bolli.
Abstract
The epsilon isoform of protein kinase C (PKCepsilon) is a member of the PKC family of serine/threonine kinases and plays a critical role in protection against ischemic injury in multiple organs. Functional proteomic analyses of PKCepsilon signaling show that this isozyme forms multiprotein complexes in the heart; however, the precise signaling mechanisms whereby PKCepsilon orchestrates cardioprotection are poorly understood. Here we report that Lck, a member of the Src family of tyrosine kinases, forms a functional signaling module with PKCepsilon. In cardiac cells, PKCepsilon interacts with, phosphorylates, and activates Lck. In vivo studies showed that cardioprotection elicited either by cardiac-specific transgenic activation of PKCepsilon or by ischemic preconditioning enhances the formation of PKCepsilon-Lck modules. Disruption of these modules, via ablation of the Lck gene, abrogated the infarct-sparing effects of these two forms of cardioprotection, indicating that the formation of PKCepsilon-Lck signaling modules is required for the manifestation of a cardioprotective phenotype. These findings demonstrate, for the first time to our knowledge, that the assembly of a module (PKCepsilon-Lck) is an obligatory step in the signal transduction that results in a specific phenotype. Thus, PKCepsilon-Lck modules may serve as novel therapeutic targets for the prevention of ischemic injury.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11854322 PMCID: PMC150872 DOI: 10.1172/JCI13200
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808